Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1) (MicroB1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02124759
Recruitment Status : Unknown
Verified February 2019 by Nicolas Musi, The University of Texas Health Science Center at San Antonio.
Recruitment status was:  Active, not recruiting
First Posted : April 28, 2014
Last Update Posted : February 7, 2019
Sponsor:
Collaborator:
American Diabetes Association
Information provided by (Responsible Party):
Nicolas Musi, The University of Texas Health Science Center at San Antonio

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : December 2019
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 10, 2020
August 25, 2020
2 August 25, 2020
September 16, 2020
3 September 16, 2020
September 22, 2020